Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-07 · accession 0001714899-25-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | 2025-01-07 | DNLI | Krognes Steve E. | Dir | S - Sale | $20.81 | -3,339 | 25.8K | -11% | -$69.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-07 | S | D | 3,339 | $20.81 | 25,757 | D | — | — | (F2) Includes 5,967 Unvested RSUs. |